AU2003201062A1 - A pharmaceutical composition useful for treating chronic myeloid leukemia - Google Patents

A pharmaceutical composition useful for treating chronic myeloid leukemia

Info

Publication number
AU2003201062A1
AU2003201062A1 AU2003201062A AU2003201062A AU2003201062A1 AU 2003201062 A1 AU2003201062 A1 AU 2003201062A1 AU 2003201062 A AU2003201062 A AU 2003201062A AU 2003201062 A AU2003201062 A AU 2003201062A AU 2003201062 A1 AU2003201062 A1 AU 2003201062A1
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
myeloid leukemia
composition useful
chronic myeloid
treating chronic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003201062A
Other languages
English (en)
Other versions
AU2003201062A8 (en
Inventor
Gautam Bandyopadhyay
Santu Bandyopadhyay
Samir Bhattacharya
Bikash Chandra Pal
Kesheb Chandra Roy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/338,688 external-priority patent/US20030229140A1/en
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of AU2003201062A8 publication Critical patent/AU2003201062A8/xx
Publication of AU2003201062A1 publication Critical patent/AU2003201062A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003201062A 2002-07-08 2003-01-10 A pharmaceutical composition useful for treating chronic myeloid leukemia Abandoned AU2003201062A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39375002P 2002-07-08 2002-07-08
US60/393,750 2002-07-08
US10/338,688 US20030229140A1 (en) 2002-05-31 2003-01-09 Herbal molecule as potential anti-leukemic drug
PCT/IB2003/000044 WO2004004708A1 (en) 2002-07-08 2003-01-10 A pharmaceutical composition useful for treating chronic myeloid leukemia
USNONE 2003-06-11

Publications (2)

Publication Number Publication Date
AU2003201062A8 AU2003201062A8 (en) 2004-01-23
AU2003201062A1 true AU2003201062A1 (en) 2004-01-23

Family

ID=30118032

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003201062A Abandoned AU2003201062A1 (en) 2002-07-08 2003-01-10 A pharmaceutical composition useful for treating chronic myeloid leukemia

Country Status (4)

Country Link
EP (1) EP1524973A1 (ja)
JP (1) JP2006519752A (ja)
AU (1) AU2003201062A1 (ja)
WO (1) WO2004004708A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2061452B1 (en) * 2006-09-01 2011-10-26 Piramal Life Sciences Limited Anti cancer use of caffeic acid and derivatives
RU2009126159A (ru) * 2006-12-21 2011-01-27 Пирамал Лайф Сайнсиз Лимитед (In) Травяная композиция и способ ее получения
KR101145930B1 (ko) * 2007-06-11 2012-05-15 국립암센터 클로로겐산을 포함하는 트란스글루타미나제 억제제 및 그의제조방법
AU2011261501B2 (en) * 2010-06-01 2016-01-21 Biotheryx, Inc. Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2904968B2 (ja) * 1991-07-25 1999-06-14 長谷川香料株式会社 色素の褪色防止剤
KR20020089440A (ko) * 2000-04-11 2002-11-29 다카라 바이오 가부시키가이샤 치료제
JP3859988B2 (ja) * 2000-07-12 2006-12-20 花王株式会社 高血圧症予防・改善・治療剤
CN1262289C (zh) * 2000-12-04 2006-07-05 科学工业研究委员会 萎叶的叶提取物在制备治疗髓性白血病的药物中的用途

Also Published As

Publication number Publication date
WO2004004708A9 (en) 2006-05-04
AU2003201062A8 (en) 2004-01-23
JP2006519752A (ja) 2006-08-31
WO2004004708A1 (en) 2004-01-15
EP1524973A1 (en) 2005-04-27

Similar Documents

Publication Publication Date Title
AU2003253439A1 (en) Method for diagnosing chronic myeloid leukemia
AU2003291103A1 (en) Pharmaceutical composition
AU2002310222A1 (en) P-cadherin as a target for anti-cancer therapy
AU2003268087A1 (en) Liposomal gemcitabine compositions for better drug delivery
AU2003286805A1 (en) Dual bevel table saw
HK1114014A1 (en) Pharmaceutical composition comprising dalbavancin
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
AU2003250372A1 (en) Pharmaceutical composition
AU2002951997A0 (en) Dispensing machine
AU2003206718A1 (en) Dosage dispenser
AU2003252310A1 (en) Knitting machine having variable rate-changing mechanism
AU2003215150A1 (en) Therapeutic compounds
AU2003211586A1 (en) Drugs containing riboflavin-type compounds
AU2003201062A1 (en) A pharmaceutical composition useful for treating chronic myeloid leukemia
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003284460A1 (en) Medicinal composition
AU2003208621A1 (en) A pharmaceutical composition
AU2002358944A1 (en) Novel anti-cancer therapeutic compounds
AU2003288611A1 (en) A synergistic composition for treating hyperlipidemia
AU2003280799A1 (en) Medicinal composition
AU2003291245A1 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml)
AU2003222571A1 (en) Novel therapeutic application for a composition
AU2003215935A1 (en) Anticancer composition
AU2003301905A1 (en) Compositions and methods for treating acute myeloid leukemia
AU2003220855A1 (en) Medicinal antitumor composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase